RWA
Redhawk Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,639
| Closed | -$1.11M | – | 318 |
|
|
2024
Q3 | $1.11M | Buy |
9,639
+807
| +9% | +$93K | 0.16% | 124 |
|
|
2024
Q2 | $1.22M | Sell |
8,832
-1,080
| -11% | -$149K | 0.19% | 110 |
|
|
2024
Q1 | $1.37M | Buy |
9,912
+463
| +5% | +$63.9K | 0.22% | 89 |
|
|
2023
Q4 | $1.25M | Buy |
+9,449
| New | +$1.25M | 0.24% | 95 |
|